Clinical Trial

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell IV Infusion for Systemic Sclerosis

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This trial will study the safety and efficacy of intravenous infusion of cultured allogeneic adult umbilical cord derived mesenchymal stem cells for the treatment of Systemic Sclerosis
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-08-17; most recent amendment 2025-04-04.
Trial Details
NCT Number NCT05016804
Lead Sponsor The Foundation for Orthopaedics and Regenerative Medicine
Conditions Systemic Sclerosis
Enrollment 20 participants
Start Date 2022-07-04
Primary Completion 2026-11 (estimated)
Study Completion 2026-11 (estimated)
Updated on ClinicalTrials.gov 2025-04-08